Planmeca introduces a new analysis tool for planning orthodontic treatments

Planmeca Romexis® is a comprehensive software used by medical and dental professionals for acquiring, viewing and processing 2D and 3D images. Planmeca now introduces a new Cephalometric Analysis module to the software in order to facilitate the daily work of orthodontists around the world. The new and easy-to-use analysis tool brings valuable benefits to orthodontic planning and treatment.

A cephalometric analysis is a study of the craniofacial relationships used particularly by orthodontists for orthodontic growth analysis, diagnosis, planning, follow-up and treatment outcome evaluation. The new Planmeca Romexis Cephalometric Analysis module provides flexible and easy-to-use features for creating cephalometric analyses and composing superimpositions of 2D cephalometric images, facial photos and images of the dental arch.
The Planmeca Romexis Cephalometric module renders routine analyses fast and easy. An analysis can be performed in minutes and the results are displayed and shared effortlessly. During a treatment process, superimposing patient images from different time points can be used for follow-up purposes. The unique concept also offers various possibilities for customizing the analysis and software properties in order to meet the needs and requirements of each dental professional. 

The Cephalometric Analysis module is a seamless part of the comprehensive Planmeca Romexis software. Images are captured in Planmeca Romexis and the cephalometric analysis can be started with just one click.  The mobile Planmeca iRomexis™ application and Planmeca’s cloud service allow sharing images and viewing results anywhere.
” We believe that with the Planmeca Romexis Cephalometric Analysis module, we can serve our orthodontics customers better than ever. Using the same system for capturing cephalometric images, CBCT images, 3D facial photos and now for creating cephalometric analyses, the customers can work more efficiently towards a better patient treatment”, states Ms Helianna Puhlin-Nurminen, Vice President of Digital Imaging and Applications division at Planmeca Oy.